JP2016504330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016504330A5 JP2016504330A5 JP2015548841A JP2015548841A JP2016504330A5 JP 2016504330 A5 JP2016504330 A5 JP 2016504330A5 JP 2015548841 A JP2015548841 A JP 2015548841A JP 2015548841 A JP2015548841 A JP 2015548841A JP 2016504330 A5 JP2016504330 A5 JP 2016504330A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- range
- pharmaceutically acceptable
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN5299CH2012 | 2012-12-18 | ||
| IN5299/CHE/2012 | 2012-12-18 | ||
| PCT/IB2013/061090 WO2014097178A1 (en) | 2012-12-18 | 2013-12-18 | Antimicrobial compounds, their synthesis and applications thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016504330A JP2016504330A (ja) | 2016-02-12 |
| JP2016504330A5 true JP2016504330A5 (https=) | 2017-01-26 |
| JP6533466B2 JP6533466B2 (ja) | 2019-06-19 |
Family
ID=54148251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548841A Expired - Fee Related JP6533466B2 (ja) | 2012-12-18 | 2013-12-18 | 抗菌性化合物、その合成およびその適用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9783490B2 (https=) |
| EP (1) | EP2934563B1 (https=) |
| JP (1) | JP6533466B2 (https=) |
| CN (1) | CN104981249B (https=) |
| AU (1) | AU2013365769B2 (https=) |
| BR (1) | BR112015014391B1 (https=) |
| CA (1) | CA2894202A1 (https=) |
| HK (1) | HK1210437A1 (https=) |
| WO (1) | WO2014097178A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105566149B (zh) * | 2016-03-02 | 2017-05-24 | 郑州大学 | 具有抗菌活性的查尔酮阳离子抗菌肽模拟物及其制备方法 |
| CN106995384B (zh) * | 2017-04-21 | 2018-12-11 | 郑州大学 | 具有抗菌活性的二烷基阳离子两亲性抗菌肽模拟物及其制备方法 |
| EP3724216A1 (en) | 2017-12-15 | 2020-10-21 | Dana Farber Cancer Institute, Inc. | Stabilized peptide-mediated targeted protein degradation |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0610487T3 (da) | 1992-09-03 | 2000-05-15 | Boehringer Ingelheim Pharma | Nye aminosyrederivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser |
| US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
| JPH09507846A (ja) * | 1993-12-30 | 1997-08-12 | スミスクライン・ビーチャム・コーポレイション | フェニルメチルヘキサンアミドおよびその使用 |
| US5663148A (en) | 1994-07-12 | 1997-09-02 | Abbott Laboratories | Anaphylatoxin receptor ligands containing lipophilic residues |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| JP3338452B2 (ja) | 1995-12-12 | 2002-10-28 | 大鵬薬品工業株式会社 | エポキシコハク酸アミド誘導体又はその塩及びこれを含有する医薬 |
| CA2217550A1 (en) * | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
| WO1999031052A1 (fr) * | 1997-12-12 | 1999-06-24 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Nouveaux inhibiteurs de metalloproteinases |
| AU2180201A (en) * | 1999-11-30 | 2001-06-12 | Aventis Pharma S.A. | Hydroxamic acid macrocyclic derivatives, preparation method and compositions containing same |
| JP2002161084A (ja) * | 2000-11-28 | 2002-06-04 | Sumitomo Pharmaceut Co Ltd | 複素環誘導体 |
| US7393836B2 (en) | 2004-07-06 | 2008-07-01 | Boehringer Ingelheim International Gmbh | D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| GB0512751D0 (en) * | 2005-06-22 | 2005-07-27 | Glaxo Group Ltd | New adjuvant |
| EP2019819A4 (en) * | 2006-05-09 | 2011-01-19 | Neobiotics Ab | INNOVATIVE PEPTIDE DERIVATIVES AS ANTIMICROBIAL AGENTS FOR THE TREATMENT OF INJURIES |
| SG175573A1 (en) * | 2006-10-04 | 2011-11-28 | Inimex Pharmaceuticals Inc | Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| JP2010512417A (ja) * | 2006-12-11 | 2010-04-22 | ワイス エルエルシー | イオンチャネルモジュレータ− |
| CN102757477B (zh) * | 2011-04-27 | 2014-09-03 | 首都医科大学 | 烯丙基半胱氨酰氨基酸甲酯衍生物及其合成方法和应用 |
| DK2709619T3 (en) * | 2011-05-16 | 2018-01-15 | Cellceutix Corp | RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS |
-
2013
- 2013-12-18 US US14/652,714 patent/US9783490B2/en not_active Expired - Fee Related
- 2013-12-18 AU AU2013365769A patent/AU2013365769B2/en not_active Ceased
- 2013-12-18 WO PCT/IB2013/061090 patent/WO2014097178A1/en not_active Ceased
- 2013-12-18 BR BR112015014391-1A patent/BR112015014391B1/pt not_active IP Right Cessation
- 2013-12-18 EP EP13865950.3A patent/EP2934563B1/en active Active
- 2013-12-18 JP JP2015548841A patent/JP6533466B2/ja not_active Expired - Fee Related
- 2013-12-18 HK HK15111327.4A patent/HK1210437A1/xx unknown
- 2013-12-18 CN CN201380070984.4A patent/CN104981249B/zh not_active Expired - Fee Related
- 2013-12-18 CA CA2894202A patent/CA2894202A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110248926A (zh) | Lsd1抑制剂及其制备方法和应用 | |
| JP2013541514A5 (https=) | ||
| UA106199C2 (ru) | Производные аминобензамида как агенты, пригодные для использования для борьбы с паразитами животных | |
| EA201001733A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| NZ607580A (en) | N-heteroaryl compounds | |
| MA53089B1 (fr) | Thiophènecarboxamides substitués et analogues comme agents antibactériens | |
| EP4606375A3 (en) | Antibacterial compounds | |
| TN2019000204A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| CA3015494C (en) | Novel compositions and therapeutic methods | |
| CU20210007A7 (es) | Derivados de aril-n-arilo para el tratamiento de una infección por virus de ácido ribonucleico (arn) | |
| CN111770756A (zh) | 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途 | |
| JP2016504330A5 (https=) | ||
| JP2014511366A5 (https=) | ||
| CN114364676A (zh) | 新型三环芳香杂环化合物,及其制备方法、药物组合物和应用 | |
| CN114269751A (zh) | 光学纯的氧杂螺环取代的吡咯并吡唑衍生物、其制法与医药上的用途 | |
| CN109689652A (zh) | 稠杂环类衍生物、其制备方法及其在医学上的应用 | |
| MA30540B1 (fr) | Derives de quinolines et compositions pharmaceutiques de ces derives. | |
| CN111406050A (zh) | 吲哚胺2,3-双加氧酶抑制剂及其用途 | |
| JP2012511558A5 (https=) | ||
| Tahiluddin et al. | A review of reported bacterial diseases and antibiotic use in tilapia culture in the Philippines | |
| JP2011508779A5 (https=) | ||
| EA201100754A1 (ru) | [4-(1-аминоэтил)циклогексил]метиламины в качестве антибактериальных средств | |
| JP2014114278A (ja) | 抗菌剤 | |
| CN116096718A (zh) | 芳基酰胺化合物、包含其的药物组合物及其制备方法和用途 | |
| CN103285399B (zh) | 一种皮上划痕用布氏菌活疫苗冻干保护剂 |